CONSTITUENT REPORT
Geraniol
Geraniol is one of the archive's most commercially important rosy-floral monoterpene alcohols and appears prominently in palmarosa, rose, citronella, geranium, and related oils. The live evidence base is strong for identity, aroma relevance, and safety framing, and it is also unusually deep for preclinical bioactivity compared with many aroma constituents. Public studies support anti-inflammatory and antifungal activity in cell and microbiology models, while safety-focused literature also shows that geraniol can oxidize or bioactivate into more potent contact allergens. For AromaForge, geraniol is best described as a high-relevance fragrance and compositional marker with meaningful preclinical literature but clear fragrance-allergen handling constraints.
Chemical identity and composition
PubChem and NIST describe geraniol as the acyclic monoterpene alcohol C10H18O. In fragrance chemistry it is the trans isomeric counterpart to nerol and a direct precursor to geranial, neral, and geranyl esters; the SCCS fragrance-allergen opinion also treats geraniol and its esters as safety-linked because oxidation or hydrolysis can generate allergenic species.
Aroma and practical use
- Use the recorded rose-like, floral, sweet, citrus-fresh, waxy descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A macrophage study found that geraniol inhibited nitric oxide and prostaglandin E2 production in lipopolysaccharide-activated cells.
The PubMed abstract directly frames geraniol as one of the characteristic geranium-oil constituents that suppressed LPS-induced inflammatory mediator production in activated macrophages.
This experimental finding does not establish benefit, dose or safety in people using this blend.
An antifungal study reported MIC activity for geraniol against Candida albicans and found inhibition of pseudohyphae and chlamydoconidia formation without evidence for cell-wall or ergosterol-binding as the main mechanism.
The PubMed abstract reports MIC90 of 16 microg/ml, time-dependent fungicidal activity, and interference with fungal morphology, while stating the probable mechanism did not involve the cell wall or ergosterol binding.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A contact-allergy mechanistic paper showed CYP-mediated activation of geraniol to geranial, neral, and epoxides, with several identified metabolites acting as moderate to strong sensitizers in LLNA testing.
The abstract identifies geranial as the main metabolite and notes that geranial, neral, and epoxy derivatives increased allergenic activity relative to geraniol itself.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe SCCS fragrance-allergen opinion treats geraniol as a relevant fragrance allergen and explicitly states that geraniol and its esters should be treated with equivalent caution when transformed into known contact allergens.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Autoxidation and metabolic activation matter for real-world handling because oxidized geraniol products can be more sensitizing than fresh raw geraniol.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Bioactivity literature for geraniol is still mostly cell, microbial, or animal work, so consumer copy should not convert those findings into medical efficacy claims.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Linalool report →CitronellolOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read Citronellol report →FarnesolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Farnesol report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Carvacrol report →NerolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · antioxidant
No source citation attached.
Read Nerol report →ThymolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Thymol report →citronellalAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citronellal report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →citralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citral report →CitronellolOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Citronellol report →EugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Eugenol report →NerolidolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
food chemistry · effect
No source citation attached.
Read Nerolidol report →How the effects were investigated
reduction of nitric oxide and prostaglandin E2 production in activated macrophages
A PubMed-indexed macrophage study reported that geraniol inhibited LPS-driven nitric oxide and prostaglandin E2 production, supporting an inflammation-modulating mechanism in vitro.
This experimental finding does not establish benefit, dose or safety in people using this blend.
interference with Candida morphogenesis and growth
Multiple antifungal studies report that geraniol inhibits Candida growth and suppresses pseudohyphae or related pathogenicity traits, although the exact target does not appear to be simple ergosterol binding.
This experimental finding does not establish benefit, dose or safety in people using this blend.
oxidative and CYP-mediated conversion to more sensitizing metabolites
The allergology literature shows geraniol can form geranial, neral, epoxides, and related oxidation products that increase sensitization potential relative to the neat raw material.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- This pass did not verify a high-quality isolated-geraniol human clinical trial suitable for consumer-facing efficacy language.
- Geraniol has a broad literature footprint, but much of the positive biological evidence remains preclinical and exposure-context dependent.
- The archive's strongest occurrence data are for a few well-profiled oils; the constituent occurs much more widely than the three retained `found_in_oils` examples.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.